Article Listing - AMA Wants To Stop Pharma Pay-To-Delay Tactic On Generics

MORE ICI PUERTO RICO INVESTMENT

16 March 1992

Imperial Chemical Industries' subsidiary IPR Pharmaceutical Inc is to make a new investment of $10 million in the development of...

CANLAC LACTULOSE PLANT FOR CANADA

16 March 1992

Canlac Corp of Canada has ann-ounced that it is to build a new pharmaceutical production facility in Victoriaville, Quebec, as...

PRODUCTION STOPS AT POLISH PLANT

16 March 1992

Production at the Rzeszow factory of the Polfa pharmaceutical enterprise has stopped, because the facility has not received $23 million...

US FDA BIOTECH REVIEW MOVES

16 March 1992

The approval of biotechnology-derived products is to be speeded up, and the US Food and Drug Administration will hire 50...

NOVO REPORTS 28% PRETAX PROFIT JUMP

16 March 1992

Danish drugmaker Novo Nordisk saw 1991 pretax income jump 28% to 1.46 billion Danish kroner ($226.4 million), on sales up...

DRUG LISTING IN ISRAEL'S KORATH

16 March 1992

In 1991, the Committee of the Korath (Israel's compendium for drug therapy) dealt with 25 applications for inclusion, of which...

ACF 1991 RESULTS

16 March 1992

- Dutch pharmaceutical wholesaler ACF Holding NV reports that 1991 net profit was boosted 68% to 23.8 million guilders ($12.7...

SHENZHEN PHARMA OUTPUT IN 1991

16 March 1992

- China's Xinhua news agency reports that the Shenzhen South China Pharmaceutical Factory has recorded a total output value of...

SALE OF FERMENTA'S INDEPENDENT

16 March 1992

- A consortium of Swedish banks is to buy Fermenta's financial subsidiary Independent for one billion Swedish kroner ($169 million),...

GANZYME'S CEREDASE 1991 SALES

16 March 1992

- Sales of Genzyme's Gaucher's disease treatment Ceredase (alglucerase) in 1991 were $39.6 million, slightly above earlier projections of $38...

Showing 94611-94620 of 95341 articles

Go to beginningPreviousNextGo to end